Accutest and Fox Chase Cancer Center - Temple Health Form Strategic Partnership on Clinical Trials for Oncology
Accutest Research Laboratories, a leading independent and internationally accredited Contract Research Organization (CRO), has formed a strategic partnership with Fox Chase Cancer Center - Temple Health for joint work on clinical trials.
The partnership aims to offer a strategic research platform for Fox Chase Cancer Center - Temple Health and Accutest Research Laboratories to conduct clinical trials in the United States, India, Southeast Asia and Latin America.
"This partnership will enable Fox Chase Cancer Center, a nationally ranked, NCI-designated comprehensive cancer center, to offer its expertise to the Asian market, expand its research and development initiatives and leverage emerging markets to the benefit of larger patient populations," said Dr. Kurt Schwinghammer, vice president for research and development alliances at Fox Chase Cancer Center - Temple Health.
Representatives of both organizations signed a non-binding memorandum of understanding on November 10, 2015, in New Delhi, India.
"Becoming a contract research organization partner with Fox Chase Cancer Center - Temple Health will allow Accutest Research Laboratories to further leverage our scientific competence, timely delivery and other capabilities to execute Phase II to IV clinical trials in emerging countries," said Dr. Satish Sawant, chief executive officer and founder of Accutest Research Laboratories.
The partnership aims to offer a strategic research platform for Fox Chase Cancer Center - Temple Health and Accutest Research Laboratories to conduct clinical trials in the United States, India, Southeast Asia and Latin America.
"This partnership will enable Fox Chase Cancer Center, a nationally ranked, NCI-designated comprehensive cancer center, to offer its expertise to the Asian market, expand its research and development initiatives and leverage emerging markets to the benefit of larger patient populations," said Dr. Kurt Schwinghammer, vice president for research and development alliances at Fox Chase Cancer Center - Temple Health.
Representatives of both organizations signed a non-binding memorandum of understanding on November 10, 2015, in New Delhi, India.
"Becoming a contract research organization partner with Fox Chase Cancer Center - Temple Health will allow Accutest Research Laboratories to further leverage our scientific competence, timely delivery and other capabilities to execute Phase II to IV clinical trials in emerging countries," said Dr. Satish Sawant, chief executive officer and founder of Accutest Research Laboratories.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.